Share

Interleukin-2 therapy immediately after autologous marrow transplantation using cryopreserved marrow for a patient with acute promyelocytic leukemia.

Author(s) : HASHINO S., IMAMURA M., KOBAYASHI S., KOBAYASHI H., TANAKA J., KASAI M., MIYAZAKI T.

Type of article: Article

Summary

Although there is only one case report, these results indicate that interleukin-2 administration immediately after autologous bone marrow transplantation using cryopreserved marrow may be safely tolerated and beneficial for elimination of minimal residual disease. Evidence of antitumour efficacy remains to be elucidated.

Details

  • Original title: Interleukin-2 therapy immediately after autologous marrow transplantation using cryopreserved marrow for a patient with acute promyelocytic leukemia.
  • Record ID : 1994-1913
  • Languages: English
  • Source: Low Temperature Medicine - vol. 19 - n. 2
  • Publication date: 1993/06
  • Document available for consultation in the library of the IIR headquarters only.

Links


See other articles in this issue (1)
See the source

Indexing